CAH
Price
$154.08
Change
+$0.01 (+0.01%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
27.26B
63 days until earnings call
HSIC
Price
$70.47
Change
+$0.08 (+0.11%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
9.7B
61 days until earnings call
Interact to see
Advertisement

CAH vs HSIC

Header iconCAH vs HSIC Comparison
Open Charts CAH vs HSICBanner chart's image
Cardinal Health
Price$154.08
Change+$0.01 (+0.01%)
Volume$15.94K
Capitalization27.26B
Henry Schein
Price$70.47
Change+$0.08 (+0.11%)
Volume$8.98K
Capitalization9.7B
CAH vs HSIC Comparison Chart
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. HSIC commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and HSIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CAH: $154.07 vs. HSIC: $70.39)
Brand notoriety: CAH and HSIC are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 57% vs. HSIC: 78%
Market capitalization -- CAH: $27.26B vs. HSIC: $9.7B
CAH [@Medical Distributors] is valued at $27.26B. HSIC’s [@Medical Distributors] market capitalization is $9.7B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileHSIC’s FA Score has 0 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • HSIC’s FA Score: 0 green, 5 red.
According to our system of comparison, CAH is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 2 TA indicator(s) are bullish while HSIC’s TA Score has 5 bullish TA indicator(s).

  • CAH’s TA Score: 2 bullish, 6 bearish.
  • HSIC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HSIC is a better buy in the short-term than CAH.

Price Growth

CAH (@Medical Distributors) experienced а -0.39% price change this week, while HSIC (@Medical Distributors) price change was -4.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.04%. For the same industry, the average monthly price growth was +0.38%, and the average quarterly price growth was -3.12%.

Reported Earning Dates

CAH is expected to report earnings on Aug 07, 2025.

HSIC is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Distributors (-0.04% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than HSIC($9.71B). CAH has higher P/E ratio than HSIC: CAH (44.47) vs HSIC (23.50). CAH YTD gains are higher at: 31.311 vs. HSIC (1.720). CAH has higher annual earnings (EBITDA): 1.89B vs. HSIC (877M). CAH has more cash in the bank: 4.59B vs. HSIC (171M). HSIC has less debt than CAH: HSIC (2.74B) vs CAH (4.72B). CAH has higher revenues than HSIC: CAH (216B) vs HSIC (12.3B).
CAHHSICCAH / HSIC
Capitalization27.3B9.71B281%
EBITDA1.89B877M216%
Gain YTD31.3111.7201,821%
P/E Ratio44.4723.50189%
Revenue216B12.3B1,756%
Total Cash4.59B171M2,685%
Total Debt4.72B2.74B172%
FUNDAMENTALS RATINGS
CAH vs HSIC: Fundamental Ratings
CAH
HSIC
OUTLOOK RATING
1..100
8264
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
259
SMR RATING
1..100
9662
PRICE GROWTH RATING
1..100
851
P/E GROWTH RATING
1..100
9362
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (68) in the Medical Distributors industry is in the same range as HSIC (78). This means that CAH’s stock grew similarly to HSIC’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is somewhat better than the same rating for HSIC (59). This means that CAH’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's SMR Rating (62) in the Medical Distributors industry is somewhat better than the same rating for CAH (96). This means that HSIC’s stock grew somewhat faster than CAH’s over the last 12 months.

CAH's Price Growth Rating (8) in the Medical Distributors industry is somewhat better than the same rating for HSIC (51). This means that CAH’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's P/E Growth Rating (62) in the Medical Distributors industry is in the same range as CAH (93). This means that HSIC’s stock grew similarly to CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHHSIC
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
56%
MACD
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
47%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 21 days ago
54%
Declines
ODDS (%)
Bearish Trend 15 days ago
47%
Bearish Trend 4 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QMOM62.710.49
+0.79%
Alpha Architect US Quantitative Momt ETF
SPHQ71.080.15
+0.21%
Invesco S&P 500® Quality ETF
APRH24.940.05
+0.20%
Innovator Premium Income 20 Bar ETF -Apr
DWUS50.01-0.26
-0.51%
AdvisorShares DW FSM US Core ETF
ETW8.40-0.05
-0.59%
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
-0.91%
COR - CAH
50%
Loosely correlated
-0.87%
MCK - CAH
48%
Loosely correlated
-0.76%
OMI - CAH
19%
Poorly correlated
-0.45%
HSIC - CAH
16%
Poorly correlated
-0.26%
SHTDF - CAH
12%
Poorly correlated
N/A
More

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
-0.26%
ZYXI - HSIC
26%
Poorly correlated
+0.47%
CAH - HSIC
20%
Poorly correlated
-0.91%
OMI - HSIC
20%
Poorly correlated
-0.45%
COR - HSIC
18%
Poorly correlated
-0.87%
SHTDY - HSIC
11%
Poorly correlated
-2.31%
More